Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose esketamine for postoperative sleep quality after gynecologic laparoscopic tumor surgery
ChiCTR2500102453Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine in sleep disorder (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Sleep efficiency on the first postoperative day. Planned start May 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2500102453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102453.